Vol. 3, Issue 2, 2020June 27, 2020 EDT
Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
Blanka Halamoda-Kenzaoui, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, Susanne Bremer-Hoffmann,
Halamoda-Kenzaoui, Blanka, Helen Box, Merel van Elk, Sandra Gaitan, Robert E. Geertsma, Eusebio Gainza Lafuente, Andrew Owen, Angel del Pozo, Matthias Roesslein, and Susanne Bremer-Hoffmann. 2020. “Launching Stakeholder Discussions on Identified Regulatory Needs for Nanotechnology-Enabled Health Products.” Precision Nanomedicine 3 (2): 608–21. https://doi.org/10.33218/001c.13521.